Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States)

被引:52
作者
Lacey, JV
Frisch, M
Brinton, LA
Abbas, FM
Barnes, WA
Gravitt, PE
Greenberg, MD
Greene, SM
Hadjimichael, OC
McGowan, L
Mortel, R
Schwartz, PE
Zaino, RJ
Hildesheim, A
机构
[1] NCI, Div Canc Epidemiol & Genet, Environm Epidemiol Branch, Hormonal Studies Sect, Rockville, MD 20852 USA
[2] Statens Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, DK-2300 Copenhagen, Denmark
[3] Sinai Hosp, Baltimore, MD 21215 USA
[4] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA
[5] Roche Mol Syst Inc, Alameda, CA USA
[6] Univ Penn, Grad Hosp, Philadelphia, PA 19104 USA
[7] Westat Corp, Rockville, MD USA
[8] Yale Univ, Sch Med, New Haven, CT USA
[9] George Washington Univ, Div Gynecol Oncol, Washington, DC USA
[10] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA
关键词
cervical adenocarcinomas; confounding; human papillomaviruses; smoking; tobacco;
D O I
10.1023/A:1008918310055
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Few studies of smoking and cervical carcinoma have addressed the rare cervical adenocarcinomas or used DNA-based tests to control for human papillomavirus (HPV) infection. Methods: This multicenter case-control study included 124 adenocarcinoma cases, 307 community controls (matched on age, race, and residence to adenocarcinoma cases), and 139 squamous carcinoma cases (matched on age, diagnosis date, clinic, and disease stage to adenocarcinoma cases). Participants completed risk-factor interviews and volunteered cervical samples for PCR-based HPV testing. Polychotomous logistic regression generated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for both histologic types. Results: Eighteen percent of adenocarcinoma cases, 43% of squamous carcinoma cases, and 22% of controls were current smokers. After control for HPV and other questionnaire data, adenocarcinomas were consistently inversely associated with smoking (e.g. current: OR = 0.6, 95% CI 0.3-1.1; greater than or equal to1 pack per day: OR = 0.7, 95% CI 0.4-1.3), while squamous carcinomas were positively associated with smoking (e.g. current: OR = 1.6, 95% CI 0.9-2.9; greater than or equal to1 pack per day: OR = 1.8, 95% CI 1.0-3.3). Results in analyses restricted to HPV-positive controls were similar. Conclusion: Smoking has opposite associations with cervical adenocarcinomas and squamous carcinomas. Although both histologic types are caused by HPV and arise in the cervix, etiologic co-factors for these tumors may differ.
引用
收藏
页码:153 / 161
页数:9
相关论文
共 65 条
[11]   Risk factors for cervical cancer in Thailand:: A case-control study [J].
Chichareon, S ;
Herrero, R ;
Muñoz, N ;
Bosch, FX ;
Jacobs, MV ;
Deacon, J ;
Santamaria, M ;
Chongsuvivatwong, V ;
Meijer, CJLM ;
Walboomers, JMM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (01) :50-57
[12]  
Franco E L, 1991, Epidemiology, V2, P98, DOI 10.1097/00001648-199103000-00003
[13]  
Grady D, 1996, CANC EPIDEMIOLOGY PR, P1058
[14]   Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method [J].
Gravitt, PE ;
Peyton, CL ;
Apple, RJ ;
Wheeler, CM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :3020-3027
[15]   SMOKING AND CERVICAL INTRAEPITHELIAL NEOPLASIA - NICOTINE AND COTININE IN SERUM AND CERVICAL-MUCUS IN SMOKERS AND NONSMOKERS [J].
HELLBERG, D ;
NILSSON, S ;
HALEY, NJ ;
HOFFMAN, D ;
WYNDER, E .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 158 (04) :910-913
[16]   PERSISTENCE OF TYPE-SPECIFIC HUMAN PAPILLOMAVIRUS INFECTION AMONG CYTOLOGICALLY NORMAL WOMEN [J].
HILDESHEIM, A ;
SCHIFFMAN, MH ;
GRAVITT, PE ;
GLASS, AG ;
GREER, CE ;
ZHANG, T ;
SCOTT, DR ;
RUSH, BB ;
LAWLER, P ;
SHERMAN, ME ;
KURMAN, RJ ;
MANES, MM .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :235-240
[17]   Natural history of cervicovaginal papillomavirus infection in young women [J].
Ho, GYF ;
Bierman, R ;
Beardsley, L ;
Chang, CJ ;
Burk, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :423-428
[18]  
Ho GYF, 1998, INT J CANCER, V78, P281, DOI 10.1002/(SICI)1097-0215(19981029)78:3&lt
[19]  
281::AID-IJC3&gt
[20]  
3.0.CO